These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 32470138)

  • 21. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
    Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
    J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional evidence that lipoprotein LpqN supports cell envelope biogenesis in
    Melly GC; Stokas H; Dunaj JL; Hsu FF; Rajavel M; Su CC; Yu EW; Purdy GE
    J Biol Chem; 2019 Oct; 294(43):15711-15723. PubMed ID: 31471317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].
    Luo H; Pang L; Xie J
    Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of residues important for M. tuberculosis MmpL11 function reveals that function is modulated by phosphorylation in the C-terminal domain.
    Melly GC; Stokas H; Davidson PM; Roma JS; Rhodes HL; Purdy GE
    Mol Microbiol; 2021 Feb; 115(2):208-221. PubMed ID: 32985735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
    Parrish NM; Kuhajda FP; Heine HS; Bishai WR; Dick JD
    J Antimicrob Chemother; 1999 Feb; 43(2):219-26. PubMed ID: 11252327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis.
    Yuan Y; Zhu Y; Crane DD; Barry CE
    Mol Microbiol; 1998 Sep; 29(6):1449-58. PubMed ID: 9781881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the formation of the cell wall core of M. tuberculosis.
    Barry CE; Crick DC; McNeil MR
    Infect Disord Drug Targets; 2007 Jun; 7(2):182-202. PubMed ID: 17970228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycolic acids from Mycobacterium tuberculosis: purification by countercurrent distribution and T-cell stimulation.
    Goodrum MA; Siko DG; Niehues T; Eichelbauer D; Verschoor JA
    Microbios; 2001; 106(413):55-67. PubMed ID: 11491525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis.
    Barkan D; Liu Z; Sacchettini JC; Glickman MS
    Chem Biol; 2009 May; 16(5):499-509. PubMed ID: 19477414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of certain lipids of Mycobacterium tuberculosis (literature review)].
    Demikhovskiĭ EI
    Probl Tuberk; 1974; (1):59-62. PubMed ID: 4218322
    [No Abstract]   [Full Text] [Related]  

  • 32. An approach for the rational design of new antituberculosis agents.
    Pasqualoto KF; Ferreira EI
    Curr Drug Targets; 2001 Dec; 2(4):427-37. PubMed ID: 11732641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid metabolism and its implication in mycobacteria-host interaction.
    Gago G; Diacovich L; Gramajo H
    Curr Opin Microbiol; 2018 Feb; 41():36-42. PubMed ID: 29190491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Mycolic Acids on Host Immunity and Lipid Metabolism.
    Wang H; Liu D; Zhou X
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
    Belardinelli JM; Yazidi A; Yang L; Fabre L; Li W; Jacques B; Angala SK; Rouiller I; Zgurskaya HI; Sygusch J; Jackson M
    ACS Infect Dis; 2016 Oct; 2(10):702-713. PubMed ID: 27737557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
    Bhat ZS; Rather MA; Maqbool M; Lah HU; Yousuf SK; Ahmad Z
    Biomed Pharmacother; 2017 Nov; 95():1520-1534. PubMed ID: 28946393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets.
    Shaku M; Ealand C; Kana BD
    Front Cell Infect Microbiol; 2020; 10():603382. PubMed ID: 33282752
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolation and analysis of Mycobacterium tuberculosis mycolic acids.
    Vilchèze C; Jacobs WR
    Curr Protoc Microbiol; 2007 Jun; Chapter 10():Unit 10A.3. PubMed ID: 18770604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis.
    Verschoor JA; Baird MS; Grooten J
    Prog Lipid Res; 2012 Oct; 51(4):325-39. PubMed ID: 22659327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria.
    Kolattukudy PE; Fernandes ND; Azad AK; Fitzmaurice AM; Sirakova TD
    Mol Microbiol; 1997 Apr; 24(2):263-70. PubMed ID: 9159514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.